By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Anavex Life Sciences Corp. 

51 West 52nd Street
7th floor
New York  New York  10019  U.S.A.
Phone: 1-844-689-3939 Fax: n/a


Company News
Anavex (AVXL) Announces Executive Overseeing Regulatory Affairs 11/25/2015 10:39:06 AM
Anavex (AVXL) To Present At American Epilepsy Society Annual Meeting ANAVEX 2-73 Demonstrates Anti-Seizure Effects In Well Established Preclinical Seizure Models 11/19/2015 11:13:50 AM
Anavex (AVXL) Announces Preparation Of Regulatory Filings Based On Guidance From FDA 11/18/2015 10:35:02 AM
Anavex (AVXL) Confirms Data For Phase 2a Alzheimer’s Trial For ANAVEX 2-73 11/11/2015 11:01:47 AM
Anavex (AVXL) Announces Positive Primary And Secondary Endpoints Were Achieved In A Phase 2a Clinical Trial Of ANAVEX 2-73 In Alzheimer’s Disease? 11/10/2015 10:02:37 AM
Anavex (AVXL) Announces CTAD 2015 Abstract 11/6/2015 9:43:40 AM
Anavex (AVXL) Commences Trading On NASDAQ Today – To Ring Friday’s Closing Bell 10/28/2015 10:27:46 AM
Anavex (AVXL) Announces Uplisting To NASDAQ 10/26/2015 11:25:08 AM
Anavex (AVXL) To Present At 4th Annual OktoberINVESTfest Conference 10/12/2015 7:38:32 AM
Anavex (AVXL) To Present Interim Phase 2a Clinical Trial Data Of ANAVEX 2-73 At Late-Breaking Oral Session Of CTAD 2015 Conference 10/7/2015 12:55:31 PM